LGND · Company research
Ligand Pharmaceuticals Inc. (LGND): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 293.26 | $6,859,001,700 | 5852299700.0 | 141.4864864864864865 | — | 0.17149877149877145721 | 107.6884696905468419 | 7.0892902029527160 | 235.4536988088290907 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.